Exercise Therapy and Ultrasound Guided Injections in Painful Shoulder

NCT01506804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2016-08-10

No results posted yet for this study

Summary

Many patients experience an effect of steroid injection, however the effect is often short lasting and recurrence of symptoms is common. The short term effect of injection has been shown to be much better than exercise therapy; however over time the superior effect of injection compared to exercise does not last. Injection in combination with exercise therapy might be a more sufficient therapy than injection alone. The aim of this study is to investigate a combination of steroid injection and a 10 week exercise program. In addition, the study tests the validity of clinical impingement tests using ultrasound verified impingement as gold standard.

Conditions

  • Shoulder Bursitis

Interventions

OTHER

methylprednisolone

Steroid injection X 2 and 10 weeks exercise program of painful shoulder vs exercise program of contralateral shoulder

Sponsors & Collaborators

  • Oak Foundation

    collaborator OTHER
  • The Danish Physiotherapy Foundation

    collaborator UNKNOWN
  • Fund for Physiotherapy in Private Practice

    collaborator UNKNOWN
  • Aase and Ejnar Danielsens Foundation

    collaborator OTHER
  • Frederiksberg University Hospital

    lead OTHER

Principal Investigators

  • Henning Bliddal, Professor · The Parker Institute, University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01506804 on ClinicalTrials.gov